VIVO Financial Facts

COST OF SALES: 17.28M
Net Sales: 47M
See Full Income Statement

Goodwill: -88.24M
Restricted cash: 1M
See Full Balance Sheet

Meridian Bioscience Inc. (VIVO) Earnings

  |   Expand Research on VIVO
Next EPS Date 9/18/26 EPS Growth Rate N/A
Average EPS % Beat Rate +39.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +5.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
9/18/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/16/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/14/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/10/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/8/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/7/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
9/3/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A
8/31/26 Q326 N/AN/A N/A N/AN/A N/A N/A N/A